Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.

HK$4.58As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2566Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 1.43%
ROE 8.50%
Biotechnology
Beta (5Y) 1.35
PE TTM 6.941
TSR TTM (45.19%)
Mkt cap HK$1.101B
ROIC 10.79%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.75
3.56%
(49.91%)
Hold 6|9|1|0|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.05
0.05
0.22%
3.59%
(0.52%)
1.60%
Revenue¥M
81.13
81.35
81.34
84.32
7.12%
2.47%
3.21%
1.41%
Peers (US$140.4M)
Cap (US$)
PE
168.3M
—
134.3M
—
Capital
TTM
5Y
10Y
Leveragex
8.506
0.173
0.124
EBIT/Intx
0.806
0.900
0.866
Own earn%
90.70
(71.74)
(86.35)
Sh yield%
43.94
26.39
29.15
Owners
Insiders/Inst%
0.55
52.03
Short interest%
3.13
SBC / revenue%
0.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
23–28
$1 testx
—
Incr. ROIC%
6